The analysis of Fpn protein levels and the MMSE (Mini-mental State Examination) scores of the patients revealed that lower Fpn protein levels were associated with more serious MMSE scores (Fig. 1F), indicating involvement of Fpn in cognitive impairment in AD. Here, SLC40A1 is linked to Alzheimer disease.